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ABSTRACT: 23-Hydroxybetulinic acid (23-HBA) is a complex lupane triterpenoid, which has attracted increasing attention as an 
anticancer agent. However, its detailed mechanism of anticancer action remains elusive so far. To reveal its anticancer mode of 
action, a series of fluorescent 23-HBA derivatives conjugated with coumarin dyes were designed, synthesized and evaluated for 
their anti-proliferative activities. Subcellular localization and uptake profile studies of representative fluorescent 23-HBA probe 26c 
were performed in B16F10 cells and the results suggested that probe 26c was rapidly taken up into B10F10 cells in a dose-
dependent manner and mitochondrion was the main site of its accumulation. Further mode of action studies implied that the 
mitochondrial pathway was involved in 23-HBA-mediated apoptosis. Together, our results provided new clues for revealing the 
molecular mechanism of natural product 23-HBA for its further development into an anti-tumor agent.  
KEYWORDS: betulinic acid, fluorescent probe, anti-tumor, mechanism, mitochondrion   
 
 
Natural products represent an enormous source of 
pharmacologically active compounds, and are often used as 
the starting point in modern drug discovery.
1
 23-
Hydroxybetulinic acid (23-HBA, 1, Fig. 1) is a natural lupane-
type pentacyclic triterpene isolated from the root of traditional 
Chinese herb Pulsatilla chinensis.
2
 In recent years, 23-HBA 
has been attracting considerable attention due to its remarkable 
antineoplastic activities.
3-6
 Several reports have indicated that 
the anticancer mechanisms of 23-HBA or its derivatives may 
be associated with depolarization of the mitochondrial 
membrane potential (MMP) and subsequent cell apoptosis.
7-8
 
However, the detailed molecular mechanism and targets 
underlying the antitumor activities of 23-HBA is still not fully 
understood. 
In recent years, much progress has been made in 
establishing methods for the identification of the cellular 
targets or mode of action (MOA) of small molecules,
9
 but 
current approaches mostly require lysis or rely on indirect 
assays. Ideal strategies that are capable of sensitive detection 
of biological processes in living systems (e.g., live cells, 
tissues, or animals) are required for the MOA studies and 
target proteins identification.
10
  
Fluorescence-based cell-imaging strategies are highly useful 
in monitoring biological processes in living cells owing to 
their practicality and high sensitivity.
11-12
 In recent years, 
fluorescently labelled probes of bioactive small molecules 
have become powerful tools to explore biological phenomena 
and provide insights into the mechanism of actions of these 
small molecules.
13-16
 With the help of fluorescently labelled 
probes, this approach makes it applicable in imaging of drug 
uptake and subcellular distribution.
17
 Besides, it can make the 
drug-target complex visible by using in-cell imaging, or in-gel 
fluorescence scanning after the sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) separation.
18
 
Figure 1. Overall strategy of fluorescent 23-HBA probe for 
subcellular localization and mechanism studies. 
In our previous studies, we have prepared hundreds of 
derivatives of 23-HBA to develop novel potential anticancer 
therapeutics.
3-6
 However, the detailed anticancer mechanism, 
mode of action, and intracellular target of 23-HBA remain 
elusive. To better understand the biological mechanism and 
illuminate mode of action of 23-HBA, Soural et al. employed 
a solid-phase synthetic approach to prepare biotinylated 23-
HBA,
19
 however, no fluorescent 23-HBA probes have been 
reported so far to the best of our knowledge.  
As our continuous interests in developing novel fluorescent 
probes of natural products for mechanism of action studies
14
, 
we herein report the synthesis, biological activities, and 
labeling performance of fluorescent 23-HBA probes. We 
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 expect that the novel fluorescent probes could provide an 
insight to understand the subcellular localization, anticancer 
mechanism of 23-HBA, and ultimately accelerate its 
development as an antitumor agent.  
Scheme 1. Synthesis of N, N-diethyl-7-aminocoumarin derivatives
 
 
Various conjugation strategies have been developed to 
construct fluorescent probes of natural products, and the most 
practical method is attaching a small-molecule fluorescent 
probe to the tolerated position of natural products with 
appropriate linkers.
20-21
 In this work, coumarin was selected as 
the fluorescent probe due to its water-solubility, small size, 
photostability and nontoxicity.
22-23
 Various linkers were 
employed because linker type and length may often affect the 
anti-proliferative activities of probes and their interactions 
with target proteins. And above all, fluorescent probes must be 
attached to the compounds at a position that does not interfere 
with target protein binding.
24
 We recently synthesized 
hundreds of derivatives of 23-HBA and found that the C-23 
hydroxy on 23-HBA can be conjugated with a bulky group 
without affecting its ability to inhibit cancer cell growth, and 
therefore could be used to attach fluorescent probes. 
Fluorescent N, N-diethyl-7-aminocoumarin dyes were 
synthesized according to the route depicted in Scheme 1. 
Briefly, 4-(diethylamino)salicylaldehyde was reacted with  
diethyl malonate in the presence of catalytic piperidine to 
yield coumarin-3-carboxylic acid ethyl ester (4). The ester was 
then hydrolyzed with sodium hydroxide to obtain acid 5. 
Compound 6 was prepared by the reaction of 5 with N-
hydroxysuccinimide in CH2Cl2. Derivatives 7a-b were 
synthesized by the reaction of compound 6 with corresponding 
amino acids while 8a-b were prepared from the corresponding 
mono-N-boc-diamines. Following deprotection of amino 
group with trifluoroacetic acid afforded 9a-b. Treated with 
succinic anhydride in the presence of DMAP, compounds 9a-
b were converted to acids 10a-b. On the other hand, 
compound 5 afforded alcohols 13a-c upon reaction with 
corresponding glycols, which were reacted with succinic 
anhydride to yield subsequent compounds 14a-c. 
Compounds 12 and 17 were synthesized by reacting with 
corresponding ethanolamines following the steps described 
above. In addition, in order to understand the impact of water-
soluble ethylene glycol linkers on anti-proliferative activities 
of target compounds, 23 was synthesized from diglycolamine. 
23-HBA was treated with BnBr in DMF to yield 28-benzyl-
23-hydroxybetulinic ester (24, Scheme 2). Compounds 7a-b  
 
were converted to acyl chloride and then reacted with ester 24 
using DMF as a catalyst in dry CH2Cl2 to give compounds 
25a-b. Target compounds 26a-b was obtained by 
debenzylation of ester 25a-b with 10% Pd/C as catalyst under 
atmospheric pressure of hydrogen. Compounds 26c-j were 
prepared in a route similar to that for 26a-b. 
 
Scheme 2. Synthesis of fluorescent 23-HBA probes 26a-j
a
 
aReagents and conditions: (a) BnBr, K2CO3, DMF, rt, 12 h; (b) 
Corresponding coumarin acids, oxalyl chloride, triethylamine, cat. 
DMF, CH2Cl2, rt, 0.5 h; (c) H2, 10% Pd/C, THF/MeOH, 50 
oC, 1 
h. 
 
Ideally, the designed natural product fluorescent probes 
must retain the activity of this natural product. The in vitro 
anti-proliferative activities of newly synthesized fluorescent 
23-HBA probes were evaluated on two cancer cell lines 
(B16F10 mice skin melanoma cells, MCF-7 human breast 
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 cancer cells) and one normal cell line (Helf human embryonic 
lung fibroblast cells) by MTT assay. The abilities of these new 
analogues to inhibit the growth of cells were summarized in 
Table 1. Most of the derivatives exhibited stronger anti-
proliferative activities than parent compound 23-HBA against 
three cell lines, especially on mice skin melanoma B16F10 
cells. The anti-proliferative activities of 26a-i showed that 
linkers with appropriate length and the introduction of amido 
groups were favorable to their anticancer activities (Table 1). 
The most potent derivatives 26c and 26d with lower IC50 
values on two tested tumor cell lines had diamine linkers while 
compounds 26e-g with ester linkers only had moderate anti-
proliferative activities ranging from 11.78 to 35.52 µM. When 
compared with 26a-b, enhanced activity of 26j indicated that 
the introduction of water-soluble ethylene glycol linkers was 
beneficial to its anti-proliferative activity. It should be noted 
that coumarin dye (10a) exhibited no obvious toxicity against 
cancer cell lines. Given the potent anti-proliferative activity of 
compound 26c, it was finally selected as the candidate for 
further studies.  
 
Table 1. Anti-proliferative activities of fluorescent 23-HBA 
probes against different cell lines 
Compounds 
Cell lines (IC50, µM)
a 
B16F10 MCF-7 Helf 
23-HBA 24.46±2.11 20.83±1.46 31.49±1.95 
26a 11.27±0.92 18.06±1.07 27.76±0.88 
26b 12.27±0.78 37.77±1.66 79.65±3.20 
26c 4.07±0.05 6.26±0.27 11.70±0.85 
26d 7.77±0.33 9.70±0.49 17.58±1.21 
26e 11.78±0.56 19.67±2.43 23.81±2.08 
26f 35.51±3.11 30.52±3.04 21.40±1.75 
26g 29.99±3.44 24.23±2.51 19.38±1.38 
26h 10.53±0.82 18.13±1.72 25.12±4.27 
26i 11.50±1.81 19.90±2.06 24.03±1.53 
26j 5.25±0.93 8.16±0.12 10.85±1.05 
10a >100 - - 
ADMb 0.19±0.03 0.15±0.02 0.21±0.02 
aEach data represents mean ± SD from three independent 
experiments; bADM: Doxorubicin. 
 
The fluorescent properties of compound 26c including the 
electronic excitation and emission spectra were evaluated 
firstly. The results showed that probe 26c exhibited significant 
differences between maximum excitation (λexc 415 nm) and 
emission (λem 475 nm) wavelength, namely stokes shift, which 
was suitable for the imaging studies (Supporting Information, 
Figure S1). Then, cell labeling property of probe 26c was 
investigated by incubating B16F10 cells with various 
concentrations of 26c in a time dependent manner. The results 
showed that probe 26c was taken up into B16F10 cells quickly, 
and distinguishable fluorescence could be detected as early as 
15 min after incubation with 10 µM 26c (Figure S2-5). To 
understand the detailed cellular uptake profile of compound 
26c in live B16F10 cells, quantitative research was carried out 
using flow cytometry. The results showed that after incubation 
with 10 µM 26c, the fluorescent intensity increased quickly at 
the beginning (0-15 min). Then, a slow growth in fluorescent 
intensity was observed during the following period of time 
(15-120 min). Subsequently, the fluorescent intensity grew 
rapidly (Figure S6). Interestingly, cells stained with naked 
coumarin dye (10a) were used as a control and the results 
showed that no obvious fluorescence could be observed after 1 
h staining with up to 50 µM of 10a (Figure S7). Considering 
the poor cell permeability and cytotoxicity of naked coumarin 
dye (10a), the above results implied the good cell permeability 
of 23-HBA.  
 
 
Figure 2. Subcellular colocalization of probe 26c with 
MitoTracker (mitochondria specific dye) in B16F10 cells. Images 
were collected using confocal microscopy with excitation of 
probe 26c at λex= 415 nm and emission at λem= 475 nm, 
MitroTracker at λex= 579 nm and emission at λem= 600 nm. 
Images are provided with amplification factor (a) enlarged view 
of representative cells, 60x, (b) 40x. 
 
The search for cellular targets may well be regarded as a 
quest for a needle in a giant haystack, the traditional affinity-
based proteomics (“pulldown”) method often suffers from 
non-specific binders.
25
 To minimize unspecific binding in 
affinity-based approaches, lysate pre-fractionation may be 
considered. Use of a particular subcellular fraction will reduce 
the sample complexity and enrich the target protein. 
Prerequisite to the fractionation is the knowledge about 
subcellular localization of the binding proteins which often 
can be obtained through colocalization study using 
fluorescently labeled compound. To understand the subcellular 
localization of 23-HBA in living cells, probe 26c and 
commercially available MitoTracker (Mitochondria specific 
dye) were employed for colocalization studies firstly. Taking 
into account the result of qualitative and quantitative research 
on cellular uptake, the minimum concentration of compound 
26c was optimized to 4 µM and the most appropriate 
incubation time was 1 h. Cells were imaged with confocal 
laser scanning microscopy. The location of probe 26c was 
viewed as green fluorescent spots upon excitation at 415 nm 
(Fig. 2, left column, green), and the MitoTracker emitted red 
fluorescence at 579 nm (Fig. 2, right column, red). 
Overlapping the fluorescent images of probe 26c and 
MitoTracker showed an extensive orange image in the same 
area (Fig. 2, middle column, orange), revealing the 
colocalization of these two probes. This observations provided 
compelling evidence for the conclusion that mitochondrion is 
the main accumulation site of 23-HBA, which was consistent 
with reports revealing that 23-HBA’s anti-tumor mechanism 
partially involved in effecting mitochondrial pathway. On the 
other hand, some non-mitochondrial regions in cells (near the 
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 nucleus) where 26c is also shown to accumulate are observed 
in Figure 2a, indicating the possibility of other proteins 
targeted by 23-HBA. To explain the specificity of the probe 
for mitochondria, comparative studies with lysosome and 
nucleus specific dyes are performed and results are shown in 
Figure 3. Overlapping of the fluorescent images arising from 
26c and LysoTracker Red (lysosome specific dye) or DAPI 
(nucleus specific dye) didn’t show obvious colocalization. As 
a result, fluorescent 23-HBA probes provided direct visual 
evidences that 23-HBA colocalized mainly with 
mitochondrion in living cell system, and following target 
identification performed with mitochondrion should be a 
priority. 
 
 
Figure 3. B16F10 cells were costained with 26c (4 µM) and 
LysoTracker Red, and then analyzed under a confocal 
microscope. Nuclei were stained with DAPI. Blue: Nucleus; red: 
LysoTracker Red, green: 26c. Micron bar: (a) 10 µm; (b) 50 µm. 
Mitochondrion plays an essential role in intrinsic pathway 
of apoptosis. Thus, commercially available fluorescent probe 
JC-1 was used to measure the MMP of B16F10 cells affected 
by 23-HBA and 26c using flow cytometry. As shown in 
Figure 4, B16F10 cells were incubated with different 
concentrations of 23-HBA (0, 7.5, 15, and 30 µM) for 48 h 
prior to staining with the JC-1, the number of cells with 
collapsed MMPs in different groups were determined by flow 
cytometry analysis, yielding 1.79%, 10.57%, 22.85%, and 
42.87% apoptotic cells, respectively. Similar decreased MMPs 
were also observed on B16F10 cells treated with 0, 1.5, 3.0, 
6.0 µM 26c, this result suggests that fluorescent conjugated 
23-HBA intracellularly behaves similar as the starting material 
23-HBA.   
 
 
Figure 4. Effect of compounds 23-HBA and 26c on the 
mitochondrial membrane potentials of B16F10 cells. Cells were 
incubated with the indicated concentrations of compounds for 48 
h prior to staining with JC-1. 
The above results showed that 23-HBA-induced apoptosis 
was closely related to the mitochondrial pathway. The Bcl-2 
family including pro-apoptotic proteins (e.g., Bax, Bad) and 
anti-apoptotic proteins (e.g., Bcl-2, Bcl-xL) has been 
identified as essential proteins in controlling the mitochondrial 
pathway. To confirm whether these proteins are involved in 
apoptosis induced by 23-HBA, the expression of Bax, Bcl-2, 
cytochrome c, caspase 3 and caspase 9 was examined by 
Western Blot analysis. As shown in Figure 5, the expression of 
Bax, cytochrome c, caspase 3 and caspase 9 began to increase 
after the treatment of 23-HBA or 26c for 48 h, while the Bcl-2 
expression decreased markedly. The above results suggested 
that mitochondrial death pathway was involved in 23-HBA-
induced apoptosis. 
 
Figure 5. Western Blotting analysis of compounds 23-HBA and 
26c on the expression of apoptosis-related proteins bax, bcl-2, 
cytochrome c, caspase 3 and caspase 9, GAPDH was used as the 
loading control. (a) B16F10 cells were treated with 23-HBA of 
various concentrations (0, 7.5, 15, and 30 µM) and 26c (0, 1.5, 
3.0, and 6.0 µM); (b) The density ratio of proteins to GAPDH was 
shown as relative expression, data was represented as mean ± SD 
of three independent experiments. (c) The density ratio between 
Bcl-2 and Bax. **P＜0.01, ***P＜0.001, control compared with 
treated cells. 
 
In summary, in order to reveal the mechanism of anticancer 
action of 23-HBA, a series of fluorescent probes of 23-HBA 
were designed and synthesized by connecting 23-hydroxyl 
group of 23-HBA with coumarin dye through various linkers. 
The pharmacological activity, uptake profile and subcellular 
localization of fluorescent 23-HBA probes were investigated 
in living cells. Qualitative and quantitative research on cellular 
uptake indicated that probe 26c was rapidly taken up by 
B16F10 cells in a dose-dependent manner. Importantly, 
colocalization studies with organelle specific dyes revealed 
that mitochondrion is the main site of its accumulation and 
subsequent mode of action studies implied that the 
mitochondrial pathway was involved in the 23-HBA-mediated 
apoptosis. Overall, our findings indicate that the novel 
fluorescent probes of 23-HBA could be used for live cell 
imaging and further to elucidate the mechanisms of anticancer 
action of 23-HBA. 
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 Supporting Information 
Experimental protocols and NMR spectra. This material is 
available free of charge via the Internet at http://pubs.acs.org.  
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